Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LATANOPROST\TIMOLOL Cause Interstitial lung disease? 15 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Interstitial lung disease have been filed in association with LATANOPROST\TIMOLOL. This represents 7.7% of all adverse event reports for LATANOPROST\TIMOLOL.

15
Reports of Interstitial lung disease with LATANOPROST\TIMOLOL
7.7%
of all LATANOPROST\TIMOLOL reports
15
Deaths
14
Hospitalizations

How Dangerous Is Interstitial lung disease From LATANOPROST\TIMOLOL?

Of the 15 reports, 15 (100.0%) resulted in death, 14 (93.3%) required hospitalization.

Is Interstitial lung disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LATANOPROST\TIMOLOL. However, 15 reports have been filed with the FAERS database.

What Other Side Effects Does LATANOPROST\TIMOLOL Cause?

Cataract (37) Glaucoma (20) Dizziness (15) Eye irritation (15) Pulmonary hypertension (15) Vision blurred (15) Pneumonitis (14) Drug ineffective (12) Dyspnoea (11) Headache (11)

What Other Drugs Cause Interstitial lung disease?

METHOTREXATE (3,049) RITUXIMAB (2,458) PEMBROLIZUMAB (2,113) PREDNISONE (1,850) CYCLOPHOSPHAMIDE (1,725) NIVOLUMAB (1,538) AMIODARONE (1,421) DOXORUBICIN (1,352) ETANERCEPT (1,267) ADALIMUMAB (1,250)

Which LATANOPROST\TIMOLOL Alternatives Have Lower Interstitial lung disease Risk?

LATANOPROST\TIMOLOL vs LATISSE LATANOPROST\TIMOLOL vs LATUDA LATANOPROST\TIMOLOL vs LAZERTINIB LATANOPROST\TIMOLOL vs LEBRIKIZUMAB-LBKZ LATANOPROST\TIMOLOL vs LECANEMAB

Related Pages

LATANOPROST\TIMOLOL Full Profile All Interstitial lung disease Reports All Drugs Causing Interstitial lung disease LATANOPROST\TIMOLOL Demographics